Merck Gets Speedy FDA Review of Keytruda in Certain Head, Neck Cancers
Merck & Co. has won U.S. Food and Drug Administration priority review for its application seeking expanded use of its blockbuster cancer drug Keytruda in certain patients with head and neck cancer.
I was diagnosed with one of the deadliest cancers which killed Steve Jobs. All I could think of was the low odds of survival. But now there's a new treatment that could tu…
Alice Rees initially put the pain under her ribs and nausea that she experienced while on holiday with friends in July 2023 ...
verywellhealth15h
What Does HPV on Your Tongue Look Like?
HPV causes irritating warts, or lesions, on the back, front, or side of the tongue. Males have a higher risk of developing ...
HPV16-Positive Head and Neck Squamous Cell Carcinoma Market is Predicted to Exhibit Remarkable Growth at a CAGR of 9.2% by 2034 | DelveInsight
KEYTRUDA monotherapy is the recommended first-line treatment for recurrent or metastatic HNSCC with high PD-L1 expression, ...
UUHC Health Feed21h
Jason Hunt, MD, MS, FACS Named Inaugural Chair of Department of Otolaryngology – Head and Neck Surgery
Professor and surgeon Jason Hunt, MD, MS, FACS, has been named inaugural Chair of the Department of Otolaryngology – Head and ...
Daijiworld3d
FMMCH hosts CME on advancements in head and neck cancer management
The departments of surgical oncology, medical oncology, and radiation oncology at Father Muller Medical College Hospital ...
Meet the Royal Stoke plastic surgeon transforming the lives of skin cancer patients
"The best part of the job is hopefully curing somebody of cancer and giving them back the life they and their family wouldn’t ...
Western Telegraph4d
Mouth ulcer warning as woman has part of her tongue cut off
A woman is urging people not to ignore mouth ulcers that don't go away - after hers turned out to be cancer and she needed 6cm of her tongue cut off ...
precisionmedicineonline4d
Cel-Sci to Initiate Phase III Trial of Immunotherapy in PD-L1-Low Head and Neck Cancer
The registrational trial will include 212 patients who are newly diagnosed with advanced head and neck cancer.
S.C. operating rooms seeing upgrades to robot-aided surgery
The Da Vinci SP made its way to the operating room for doctors at Trident Medical Center. The robot that uses a single port, ...
CEL-SCI to Initiate Multikine Confirmatory Phase 3 Cancer Trial
Confirmatory Phase 3 Trial Designed to Support Commercialization of Multikine for Head and Neck Cancer Treatment. Full enrollment expected by Q2 2026 with plans to seek early appr ...